Jump Trading’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Jump Trading’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-2,000	Closed	-$285K	–	605
2016 Q2	$285K	Buy	+2,000	New	+$292K	0.01%	549
2016 Q1	–	Sell	-14	Closed	-$209K	–	797
2015 Q4	$209K	Buy	+14	New	+$2.37K	0.01%	696
2015 Q3	–	Sell	-800	Closed	-$193K	–	1073
2015 Q2	$193K	Hold	800	–	–	﹤0.01%	697
2015 Q1	$226K	Buy	+800	New	+$173K	0.01%	587
2014 Q4	–	Sell	-600	Closed	-$142K	–	1235
2014 Q3	$142K	Sell	600 -1,700	-74%	-$433K	﹤0.01%	704
2014 Q2	$544K	Buy	+2,300	New	+$606K	0.02%	279

Other funds holding ICPT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Jump Trading's ICPT Position: Q4 2019 in Review

Jump Trading sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2019, closing a stake of 3,121 shares — an estimated $207K sold.

Jump Trading first reported a position in ICPT in Q2 2014 and held it in 5 quarters. The position peaked at $294K in Q3 2014. 215 funds tracked by Wall St. Rank hold ICPT as of Q4 2019.

Jump Trading reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2019 after selling out during the quarter.
Jump Trading sold 3,121 Intercept Pharmaceuticals, Inc. shares in Q4 2019, an estimated $207K.
Jump Trading first reported a position in Intercept Pharmaceuticals, Inc. in Q2 2014 and held it in 5 quarters.
Jump Trading's Intercept Pharmaceuticals, Inc. position peaked at $294K in Q3 2014.
215 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2019.

Based on Jump Trading's 13F filing for Q4 2019, filed 14 Feb 2020.